Table 2 Clinical outcomes occurred during follow-up
|  | Study population (n = 50) |
|---|---|
At 1Â year | |
 Dead, n (%) | 16 (32.0) |
Major amputation, n (%) | |
 All patients (n = 50) | 8 (16.0) |
 Alive at 1 year (n = 34) | 7 (20.6) |
Ulcer healing, n (%) | |
  All patients (n = 50) | 22 (44.0) |
  Alive at 1 year (n = 34) | 21 (61.8) |
Ulcer healing without a major amputation, n (%) | |
  All patients (n = 50) | 17 (34.0) |
  Alive at 1 year (n = 34) | 16 (47.1) |
Estimated* time to healing without a major amputation (days), mean ± SE | 257 ± 17 |
At the end of follow-up | |
 Follow-up time (years), median [IQR] | 1.46 [0.55–2.01] |
 Dead, n (%) | 24 (48.0) |
 Major amputation, n (%) | |
  All patients (n = 50) | 9 (18.0) |
  Alive at the end of follow-up (n = 26) | 5 (19.3) |
 Walking capability, n (%) | |
  All patients (n = 50) | 30 (60.0) |
  Alive at the end of follow-up (n = 26) | 23 (88.5) |
 Ulcer healing, n (%) | |
  All patients (n = 50) | 30 (60.0) |
  Alive at the end of follow-up (n = 26) | 23 (88.5) |
 Ulcer healing without a major amputation, n (%) | |
  All patients (n = 50) | 25 (50.0) |
  Alive at the end of follow-up (n = 26) | 19 (73.1) |
 Estimated* time to healing without a major amputation (days), mean ± SE | 345 ± 39 |